Lisata Therapeutics LSTA
NASDAQ LSTA
$1.47 -0.02 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Lisata Therapeutics (LSTA) recorded Return on Capital Employed [ROCE] of -171.90% in Q2 2026, down 79.63 percentage points from -92.28% a year earlier and down 34.43 percentage points from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Lisata Therapeutics reported Return on Capital Employed [ROCE] of -78.14%, down 21.03 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -9.94 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -57.11% in FY2024 (-12.23 pp), -44.89% in FY2023 (+28.36 pp), -73.25% in FY2022 (-26.38 pp) and -46.87% in FY2021 (+21.33 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q3 2016.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for eight consecutive quarters, with an average year-over-year change of -38.94 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 37.76 percentage points in Q2 2024, against a drop of 79.63 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -137.47% (Q1 2026), -109.16% (Q4 2025) and -106.28% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Lisata Therapeutics 13.40 Mn 13.15 Mn - -171.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -171.90%
Mar 31, 2026 -137.47%
Dec 31, 2025 -109.16%
Sep 30, 2025 -106.28%
Jun 30, 2025 -92.28%
Mar 31, 2025 -76.83%
Dec 31, 2024 -72.32%
Sep 30, 2024 -65.80%
Jun 30, 2024 -58.89%
Mar 31, 2024 -55.20%
Dec 31, 2023 -51.62%
Sep 30, 2023 -47.60%
Jun 30, 2023 -96.65%
Mar 31, 2023 -89.80%
Dec 31, 2022 -83.00%
Sep 30, 2022 -76.39%
Jun 30, 2022 -31.83%
Mar 31, 2022 -30.17%
Dec 31, 2021 -30.50%
Sep 30, 2021 -27.24%
API Access

Lisata Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LSTA&period=max&api_key=YOUR_API_KEY